Latest news
Loading news…
Onco-Innovations
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Calgary, Alberta, Canada Founded 2024 1-10 employees For Profit
Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Ticker
ONCO
CNSX - Canadian National Stock Exchange
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- ONCO
- Exchange
- CNSX - Canadian National Stock Exchange
- IPO date
- Nov 26, 2024
- Raised at IPO
- $3M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 20
- IT spend
- $9K
Company Info
- Founded
- 2024
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Sub-organizations
- 1
- News articles
- 147
- HQ
- Calgary, Alberta, Canada
- Exit date
- Nov 26, 2024
Signals & Scores
- Heat score
- High
- Growth score
- High
- Trend (7d)
- 0.4
- Trend (30d)
- 4
- Trend (90d)
- 8.9
- Last leadership hire
- Jun 5, 2026
Acquisitions by Onco-Innovations
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Onco-Innovations
Loading news…
FAQs about Onco-Innovations
People who checked this page also checked these
Sectors Onco-Innovations invests & acquires in
Browse the full Acquirezy directory.